Treatment Outcomes for Patients Undergoing Hemodialysis with Chronic Hepatitis C on the Sofosbuvir and Daclatasvir Regimen

Background Hepatitis C (HCV) infection is the most commonly acquired infection for patients on hemodialysis and is associated with significant morbidity and disease progression. Direct-acting antivirals (DAAs) have revolutionized the management of HCV. However, limited data exist regarding their eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Butt, Nazish, Abbasi, Amanullah, Ali Khan, M, Ali, Muhammad, Mahesar, Ghulam B, Haleem, Farhan, Manan, Abdul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Gastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823026/
https://www.ncbi.nlm.nih.gov/pubmed/31720170
http://dx.doi.org/10.7759/cureus.5702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823026/
https://www.ncbi.nlm.nih.gov/pubmed/31720170
http://dx.doi.org/10.7759/cureus.5702

Ejemplares similares